Jun 22, 2020
New Preclinical Data on ALKS 4230 in Combination With Lucitanib to be Presented at 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
Jun 01, 2020
Camurus Announces Submission of Request for Final Approval of Brixadi(TM) for the Treatment of Opioid Use Disorder in the US
Jun 01, 2020
Braeburn Submits Request for Final Approval of BRIXADI(TM) (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder
Mar 04, 2020
Journal of Clinical Psychiatry Publishes Data from Alkermes' Phase 3 ENLIGHTEN-1 Efficacy Study of ALKS 3831 in Patients With Schizophrenia
Jan 29, 2020
Promising Results From Human PK Study Assessing Novel Ketorolac Formulations for Treatment of Pain
Jan 28, 2020
Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder
Jan 07, 2020
Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Digital Technology to Improve Medication-Assisted Treatment in Primary Care
Dec 02, 2019
New Analysis From One-Year Study of Monthly Buprenorphine Extended-Release Injections Showed Improved or Stable Patient-Centered Outcomes
Nov 25, 2019
Camurus Announces New Study Results Showing Superior Patient Reported Outcomes With Buvidal® Versus Standard of Care in Treatment of Opioid Dependence
Nov 19, 2019
Alkermes Submits New Drug Application to U.S. Food and Drug Administration for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder
Nov 04, 2019
Alkermes to Present Data From ALKS 4230 Clinical Development Program at the Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting
Oct 18, 2019
Global Opioid Overdose Pipeline Insights Report 2019
Oct 01, 2019
SaVida Health, a Leading Provider of Outpatient Opioid and Alcohol Addiction Treatment Services, Opens in West Springfield, MA
Sep 20, 2019
Statement from Acting FDA Commissioner Ned Sharpless, M.D., on continued efforts to increase availability of all forms of naloxone to help reduce opioid overdose deaths
Sep 12, 2019
Comagine Health participates in study to reduce the risk of post-incarceration opioid overdose in women
Sep 11, 2019
In fight to end nation's opioid crisis, a new treatment approach emerges
Aug 08, 2019
BayMark Health Services Opens AppleGate Recovery In Blacksburg, Va
Jul 30, 2019
The Government of Canada increases access to treatment for opioid use disorder in Alberta
Jul 29, 2019
Online Platform Provides Life-Saving Opioid Antidote; Expands To Pennsylvania & West Virginia On August 1
Jul 23, 2019
Camurus Announces Positive Outcome of U.S. Court Proceeding About Final Approval of Brixadi(TM)